Mint Tower Capital Management B.V. Eli Lilly & CO Call Options Transaction History

Mint Tower Capital Management B.V.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 02, 2021	SELL	$180.55 - $233.54 $1.08 Million - $1.4 Million	-6,000 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $985,920 - $1.28 Million	6,000 New	6,000 $1.12 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $5,565 - $6,551	-50 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $5,295 - $5,932	50 New	50 $5,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

Stay updated on Mint Tower Capital Management B.V. with notifications on news.